Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT00186303
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- adequate organ function
Stanford University
Other
Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03204188
B-Lymphocytic Leukemia, Chronic, B-cell Chronic Lymphocytic Leukemia
Bethesda, Maryland, United States
View Trial DetailsNCT04626843
Behavior, Behavior, Animal
Victoria, British Columbia, Canada
View Trial DetailsNCT04030195
B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma
Duarte, California, United States
View Trial DetailsNCT02758665
Chronic Disease, Disease Attributes
Cologne, Germany
View Trial Details